Patterns of use, effectiveness and safety of gadolinium contrast agents: a European prospective cross-sectional multicentre observational study

BACKGROUND: The EU gadolinium-based contrast agents (GBCA) market has changed in recent years due to the European Medicines Agency decision to suspend the marketing authorisation of linear GBCA and the marketing authorisation of new generic macrocyclic GBCA. The study aims to understand the patterns...

Descripción completa

Detalles Bibliográficos
Autores principales: Jakobsen, Jarl Åsbjørn, Quattrocchi, Carlo Cosimo, Müller, Frank H. H., Outteryck, Olivier, Alcázar, Andrés, Reith, Wolfgang, Fraga, Patricia, Panebianco, Valeria, Sampedro, Alexis, Pietura, Radoslaw
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056663/
https://www.ncbi.nlm.nih.gov/pubmed/33879075
http://dx.doi.org/10.1186/s12880-021-00600-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056663/
https://www.ncbi.nlm.nih.gov/pubmed/33879075
http://dx.doi.org/10.1186/s12880-021-00600-9

Ejemplares similares